A New Algorithm to Predict Ovarian Age
Launched by UNIVERSITY MAGNA GRAECIA · Mar 11, 2014
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
The normal process of reproductive aging varies considerably among women. This implies that some women remain highly fertile until the fifth decade of their life, whereas others face the loss of natural fertility already in their mid-thirties. Female reproductive aging seems to be largely based on age related changes in ovarian function. Decreasing numbers of follicles, coinciding with diminished oocyte quality, dictate the gradual changes in menstrual cycle regularity and monthly fecundity which inevitable evolution will be menopause. The mechanisms behind the observed gradual decline of t...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 18 and 55 years
- • Consent to participate to the prospective study
- • Regular menses at 22 to 35 day interval
- Exclusion Criteria:
- • Estrogen or progestin-containing medications in the month before enrollment
- • Gynecological malignancy
- • Hypogonadotropic hypogonadism
- • Assumption of drugs that can cause menstrual irregularity
About University Magna Graecia
University Magna Graecia is a prestigious academic institution dedicated to advancing medical research and education. Located in Catanzaro, Italy, the university is committed to fostering innovation in clinical trials and promoting evidence-based healthcare practices. With a robust network of experienced researchers and clinicians, University Magna Graecia focuses on conducting high-quality clinical studies that aim to improve patient outcomes and contribute to the global medical community. Their research initiatives are characterized by a strong emphasis on ethical standards, collaboration, and the integration of cutting-edge scientific methodologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Catanzaro, Cz, Italy
Patients applied
Trial Officials
Fulvio Zullo
Study Director
Magna Graecia University of Catanzaro
Roberta Venturella, MD
Principal Investigator
Magna Graecia University of Catanzaro
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials